istopmm analysis results: autoimmune diseases are not associated with mgus
Published 1 year ago • 370 plays • Length 2:47Download video MP4
Download video MP3
Similar videos
-
0:42
istopmm: a new, large & unbiased mgus patient population
-
5:11
istopmm: the psychological effects of mgus screening and changes to clinical presentation of myeloma
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
3:23
molecular characteristics associated with increased risk of disease progression in smm
-
1:36
multivariate model to predict the need for bone marrow sampling in patients with mgus
-
8:07
mgus with multiple paraproteins: results from the population-based istopmm screening study
-
5:55
mgus and risk of chronic kidney disease: results of the population-based istopmm study
-
1:02:06
interpreting mgus/smoldering myeloma labs- what to know and when to take action
-
4:02
the association between chip and mgus
-
2:42
the importance of better identifying individuals with mgus & the possibility of treating precursors
-
1:43
an insight into the prevalence of various subtypes of mgus in the istopmm study
-
1:50
long non-coding rna expression in igm-mgus and waldenström’s macroglobulinemia
-
2:01
redefining mgus to better predict progression to active disease
-
5:26
updates from the istopmm study
-
1:42
immune profiling & mrd negativity of ndmm treated with quadruplet induction autosct: milestone trial
-
4:41
first results of promise: mgus screening in a high-risk population
-
3:15
the current state of cardiac transplantation for al and attr amyloidosis
-
0:44
istopmm study – the impact of nationwide screening
-
2:06
understanding the role of inflammation and the immunome in mds pathophysiology
-
3:19
an efficacy sub-analysis from the ace-536-mf-001 study of luspatercept for mf-related anemia
-
2:49
the role of the immune system in the pathophysiology of mds
-
1:05
istopmm: benefits and harms of screening for myeloma precursor disease